On July 14, 2023, Cadrenal Therapeutics, Inc. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4106 USD | 0.00% | -2.24% | -44.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.51% | 6.57M | |
+38.09% | 727B | |
-7.44% | 354B | |
+15.67% | 328B | |
-0.11% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.18% | 164B | |
-1.77% | 164B |
- Stock Market
- Equities
- CVKD Stock
- News Cadrenal Therapeutics, Inc.
- Cadrenal Therapeutics, Inc. announced that it has received $7.500001 million in funding